|
|
|
|
FDA804
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies
|
|
|
FDA804-1
Normal human organ tissue array (slide 1 of 2 slide set), replacing FDA803-1, recommended by FDA to test tissue specificity, 72 cases/72 cores, replaced by FDA805-1
|
|
| Microarray Panel: | FDA normal organ tissue microarray of human, 24 types of normal organs (adrenal gland, bone marrow, breast, cerebellum tissue, cerebrum, colon, esophagus, heart, hypophysis, intestine, kidney, liver, lung, ovary, pancreas, parathyroid gland, prostate, salivary gland, spleen, stomach, testis, thyroid, thymus, tonsil), each organ taken from 3 normal human individuals, together with FDA804-2 to make FDA804 set, single core per case |
| Cores: | 72 |
|
| Cases: | 72 |
| Layout: | 9 cols × 8 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Vimentin (Vim) confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
Microarray Panel Display  | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| A |
|
|
|
|
|
|
|
|
|
| B |
|
|
|
|
|
|
|
|
|
| C |
|
|
|
|
|
|
|
|
|
| D |
|
|
|
|
|
|
|
|
|
| E |
|
|
|
|
|
|
|
|
|
| F |
|
|
|
|
|
|
|
|
|
| G |
|
|
|
|
|
|
|
|
|
| H |
|
|
|
|
|
|
|
|
|
|
| Legend: | Adr - Adrenal gland,
Bon - Bone marrow,
Bre - Breast,
Ceb - Cerebellum tissue,
Cer - Cerebrum,
Col - Colon,
Eso - Esophagus,
Hea - Heart,
Hyp - Hypophysis,
Int - Intestine,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Ova - Ovary,
Pan - Pancreas,
Par - Parathyroid gland,
Pro - Prostate,
Sal - Salivary gland,
Spl - Spleen,
Sto - Stomach,
Tes - Testis,
Thr - Thyroid,
Thy - Thymus,
Ton - Tonsil
- Normal tissue
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Type † |
|
A1 |
1 |
F |
2 |
Cerebrum |
Normal cerebral tissue |
Normal |
|
A2 |
2 |
F |
50 |
Cerebrum |
Normal cerebral tissue |
Normal |
|
A3 |
3 |
F |
42 |
Cerebrum |
Normal cerebral tissue |
Normal |
|
A4 |
4 |
F |
24 |
Cerebellum |
Normal cerebellar tissue |
Normal |
|
A5 |
5 |
F |
58 |
Cerebellum |
Normal cerebellar tissue |
Normal |
|
A6 |
6 |
F |
8 |
Cerebellum |
Normal cerebellar tissue |
Normal |
|
A7 |
7 |
F |
14 |
Adrenal gland |
Normal adrenal gland tissue |
Normal |
|
A8 |
8 |
M |
1 Mon. |
Adrenal gland |
Normal adrenal gland tissue |
Normal |
|
A9 |
9 |
M |
5 Mon. |
Adrenal gland |
Normal adrenal gland tissue |
Normal |
|
B1 |
10 |
F |
14 |
Ovary |
Normal ovarial tissue |
Normal |
|
B2 |
11 |
F |
20 |
Ovary |
Normal ovarial tissue |
Normal |
|
B3 |
12 |
F |
21 |
Ovary |
Normal ovarial tissue |
Normal |
|
B4 |
13 |
F |
14 |
Pancreas |
Normal pancreatic tissue |
Normal |
|
B5 |
14 |
F |
2 |
Pancreas |
Normal pancreatic tissue |
Normal |
|
B6 |
15 |
F |
52 |
Pancreas |
Normal pancreatic tissue |
Normal |
|
B7 |
16 |
M |
43 |
Parathyroid gland |
Normal parathyroid gland tissue |
Normal |
|
B8 |
17 |
F |
22 |
Parathyroid gland |
Normal parathyroid tissue and thyroid gland tissue |
Normal |
|
B9 |
18 |
M |
45 |
Parathyroid gland |
Normal parathyroid gland tissue |
Normal |
|
C1 |
19 |
F |
15 |
Hypophysis |
Normal hypophysis tissue |
Normal |
|
C2 |
20 |
M |
20 |
Hypophysis |
Normal hypophysis tissue |
Normal |
|
C3 |
21 |
F |
25 |
Hypophysis |
Normal hypophysis tissue |
Normal |
|
C4 |
22 |
M |
30 |
Testis |
Normal testis tissue |
Normal |
|
C5 |
23 |
M |
65 |
Testis |
Normal testis tissue |
Normal |
|
C6 |
24 |
M |
74 |
Testis |
Normal testis tissue |
Normal |
|
C7 |
25 |
F |
25 |
Thyroid |
Normal thyroid gland tissue |
Normal |
|
C8 |
26 |
M |
37 |
Thyroid |
Normal thyroid gland tissue |
Normal |
|
C9 |
27 |
F |
58 |
Thyroid |
Normal thyroid gland tissue |
Normal |
|
D1 |
28 |
F |
50 |
Breast |
Normal breast tissue (fibrofatty tissue) |
Normal |
|
D2 |
29 |
F |
32 |
Breast |
Normal breast tissue |
Normal |
|
D3 |
30 |
F |
33 |
Breast |
Normal breast tissue |
Normal |
|
D4 |
31 |
F |
2 |
Spleen |
Normal spleen tissue |
Normal |
|
D5 |
32 |
M |
35 |
Spleen |
Normal spleen tissue |
Normal |
|
D6 |
33 |
M |
30 |
Spleen |
Normal spleen tissue |
Normal |
|
D7 |
34 |
M |
48 |
Tonsil |
Normal tonsilar tissue |
Normal |
|
D8 |
35 |
M |
35 |
Tonsil |
Normal tonsilar tissue |
Normal |
|
D9 |
36 |
M |
48 |
Tonsil |
Normal tonsilar tissue |
Normal |
|
E1 |
37 |
M |
1 Mon. |
Thymus |
Normal thymus tissue |
Normal |
|
E2 |
38 |
F |
2 |
Thymus |
Normal thymus tissue |
Normal |
|
E3 |
39 |
M |
1 Mon. |
Thymus |
Normal thymus tissue |
Normal |
|
E4 |
40 |
M |
56 |
Bone marrow |
Normal myeloid tissue |
Normal |
|
E5 |
41 |
F |
61 |
Bone marrow |
Normal myeloid tissue |
Normal |
|
E6 |
42 |
M |
70 |
Bone marrow |
Normal myeloid tissue |
Normal |
|
E7 |
43 |
M |
24 |
Lung |
Normal pulmonary tissue |
Normal |
|
E8 |
44 |
M |
42 |
Lung |
Normal pulmonary tissue |
Normal |
|
E9 |
45 |
M |
49 |
Lung |
Normal pulmonary tissue |
Normal |
|
F1 |
46 |
M |
56 |
Heart |
Normal myocardial tissue |
Normal |
|
F2 |
47 |
F |
42 |
Heart |
Normal myocardial tissue |
Normal |
|
F3 |
48 |
F |
35 |
Heart |
Normal myocardial tissue |
Normal |
|
F4 |
49 |
M |
32 |
Esophagus |
Normal esophageal tissue |
Normal |
|
F5 |
50 |
F |
21 |
Esophagus |
Normal esophageal tissue (smooth muscle) |
Normal |
|
F6 |
51 |
F |
42 |
Esophagus |
Normal esophageal tissue |
Normal |
|
F7 |
52 |
M |
48 |
Stomach |
Normal gastric fundus tissue |
Normal |
|
F8 |
53 |
M |
5 Mon. |
Stomach |
Normal gastric fundus tissue |
Normal |
|
F9 |
54 |
M |
40 |
Stomach |
Normal gastric fundus tissue |
Normal |
|
G1 |
55 |
M |
40 |
Intestine |
Normal small intestine tissue |
Normal |
|
G2 |
56 |
M |
38 |
Intestine |
Normal small intestine tissue |
Normal |
|
G3 |
57 |
M |
49 |
Intestine |
Normal small intestine tissue |
Normal |
|
G4 |
58 |
M |
62 |
Colon |
Normal colonic tissue |
Normal |
|
G5 |
59 |
F |
42 |
Colon |
Normal colonic tissue |
Normal |
|
G6 |
60 |
M |
35 |
Colon |
Normal colonic tissue |
Normal |
|
G7 |
61 |
F |
14 |
Liver |
Normal hepatic tissue |
Normal |
|
G8 |
62 |
F |
35 |
Liver |
Normal hepatic tissue |
Normal |
|
G9 |
63 |
M |
35 |
Liver |
Normal hepatic tissue |
Normal |
|
H1 |
64 |
M |
50 |
Salivary gland |
Normal salivary gland tissue |
Normal |
|
H2 |
65 |
M |
77 |
Salivary gland |
Normal salivary gland tissue |
Normal |
|
H3 |
66 |
M |
28 |
Salivary gland |
Normal salivary gland tissue |
Normal |
|
H4 |
67 |
F |
14 |
Kidney |
Normal renal tissue |
Normal |
|
H5 |
68 |
M |
48 |
Kidney |
Normal renal tissue |
Normal |
|
H6 |
69 |
F |
38 |
Kidney |
Normal renal tissue |
Normal |
|
H7 |
70 |
M |
27 |
Prostate |
Normal prostatic tissue |
Normal |
|
H8 |
71 |
M |
25 |
Prostate |
Normal prostatic tissue |
Normal |
|
H9 |
72 |
M |
36 |
Prostate |
Normal prostatic tissue |
Normal |
† For precise diagnosis, refer to pathology description.
|
FDA804-2
Multiple tumor and 6 types of normal organ tissue array (slide 2 of 2 slide set), replacing FDA803-2, recommended by FDA to test tissue specificity, 72 cases/72 cores, replaced by FDA807-2
|
|
| Microarray Panel: | Multiple tumor and normal tissue microarray, 54 cases of tumor of varieties of organ tissue and 6 types of normal organ (Uterus, Cervix, Striated muscle, Skin, Nerve, Mesothelium), each organ taken from 3 normal human individuals, together with FDA804-1 to make FDA804 set, single core per case |
| Cores: | 72 |
|
| Cases: | 72 |
| Layout: | 9 cols × 8 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Actin confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display  | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
| A |
|
|
|
|
|
|
|
|
|
|
| B |
|
|
|
|
|
|
|
|
|
|
| C |
|
|
|
|
|
|
|
|
|
|
| D |
|
|
|
|
|
|
|
|
|
|
| E |
|
|
|
|
|
|
|
|
|
|
| F |
|
|
|
|
|
|
|
|
|
|
| G |
|
|
|
|
|
|
|
|
|
|
| H |
|
|
|
|
|
|
|
|
|
 |
|
| Legend: | Bla - Bladder,
Bon - Bone,
Bra - Brain,
Bre - Breast,
Col - Colon,
Eso - Esophagus,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Lym - Lymph node,
Med - Mediastinum,
Mes - Mesothelium,
Ner - Nerve,
Ova - Ovary,
Pan - Pancreas,
Per - Peritoneum,
Pro - Prostate,
Rec - Rectum,
Ret - Retroperitoneum,
Ski - Skin,
Sma - Small intestine,
Smo - Smooth muscle,
Spl - Spleen,
Sto - Stomach,
Str - Striated muscle,
Tes - Testis,
Thr - Thyroid,
Ute - Uterine cervix
- Benign tumor,
- Malignant tumor,
- Normal tissue
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
|
A1 |
1 |
F |
21 |
Uterus |
Normal endometrial tissue |
– |
Normal |
|
A2 |
2 |
F |
21 |
Uterus |
Normal endometrial tissue |
– |
Normal |
|
A3 |
3 |
F |
58 |
Uterus |
Normal endometrial tissue |
– |
Normal |
|
A4 |
4 |
F |
15 |
Uterine cervix |
Normal cervix tissue |
– |
Normal |
|
A5 |
5 |
F |
21 |
Uterine cervix |
Normal cervix tissue |
– |
Normal |
|
A6 |
6 |
F |
35 |
Uterine cervix |
Normal cervix tissue |
– |
Normal |
|
A7 |
7 |
M |
40 |
Striated muscle |
Normal skeletal muscle tissue |
– |
Normal |
|
A8 |
8 |
M |
30 |
Striated muscle |
Normal skeletal muscle tissue (sparse) |
– |
Normal |
|
A9 |
9 |
M |
40 |
Striated muscle |
Normal skeletal muscle tissue (sparse) |
– |
Normal |
|
B1 |
10 |
M |
35 |
Skin |
Normal dermatic tissue |
– |
Normal |
|
B2 |
11 |
M |
40 |
Skin |
Normal dermatic tissue |
– |
Normal |
|
B3 |
12 |
M |
40 |
Skin |
Normal dermatic tissue |
– |
Normal |
|
B4 |
13 |
F |
15 |
Nerve |
Normal nerve tissue (sparse) |
– |
Normal |
|
B5 |
14 |
M |
22 |
Nerve |
Normal nerve tissue |
– |
Normal |
|
B6 |
15 |
F |
62 |
Nerve |
Normal nerve tissue (fibrous tissue and blood vessel) |
– |
Normal |
|
B7 |
16 |
M |
48 |
Mesothelium |
Normal mesothelium and lung tissue (sparse) |
– |
Normal |
|
B8 |
17 |
M |
22 |
Mesothelium |
Normal mesothelium and lung tissue (sparse) |
– |
Normal |
|
B9 |
18 |
M |
40 |
Mesothelium |
Normal mesothelium tissue (lung tissue) |
– |
Normal |
|
C1 |
19 |
M |
39 |
Brain |
Glioblastoma |
– |
Malignant |
|
C2 |
20 |
M |
43 |
Brain |
Atypical meningioma |
– |
Malignant |
|
C3 |
21 |
F |
15 |
Brain |
Malignant ependymoma |
– |
Malignant |
|
C4 |
22 |
F |
61 |
Brain |
Malignant oligodendroglioma |
– |
Malignant |
|
C5 |
23 |
F |
53 |
Ovary |
Serous papillary adenocarcinoma |
3 |
Malignant |
|
C6 |
24 |
F |
29 |
Ovary |
Mucinous papillary adenocarcinoma |
2–3 |
Malignant |
|
C7 |
25 |
F |
12 |
Pancreas |
Islet cell carcinoma |
– |
Malignant |
|
C8 |
26 |
M |
64 |
Pancreas |
Adenocarcinoma |
3 |
Malignant |
|
C9 |
27 |
M |
32 |
Testis |
Seminoma (sparse) |
– |
Malignant |
|
D1 |
28 |
M |
30 |
Testis |
Embryonal carcinoma |
– |
Malignant |
|
D2 |
29 |
F |
33 |
Thyroid |
Medullary carcinoma |
– |
Malignant |
|
D3 |
30 |
M |
36 |
Thyroid |
Papillary carcinoma |
– |
Malignant |
|
D4 |
31 |
F |
50 |
Breast |
Intraductal carcinoma |
– |
Malignant |
|
D5 |
32 |
F |
49 |
Breast |
Lobular carcinoma in situ (breast tissue) |
– |
Malignant |
|
D6 |
33 |
F |
39 |
Breast |
Invasive ductal carcinoma |
2 |
Malignant |
|
D7 |
34 |
M |
21 |
Spleen |
Diffuse B-cell lymphoma |
– |
Malignant |
|
D8 |
35 |
F |
45 |
Lung |
Small cell undifferentiated carcinoma |
4 |
Malignant |
|
D9 |
36 |
M |
74 |
Lung |
Squamous cell carcinoma (sparse) with necrosis |
3 |
Malignant |
|
E1 |
37 |
F |
59 |
Lung |
Adenocarcinoma |
3 |
Malignant |
|
E2 |
38 |
M |
50 |
Esophagus |
Squamous cell carcinoma |
2 |
Malignant |
|
E3 |
39 |
F |
67 |
Esophagus |
Adenocarcinoma |
3 |
Malignant |
|
E4 |
40 |
F |
73 |
Stomach |
Mucinous adenocarcinoma |
3 |
Malignant |
|
E5 |
41 |
F |
51 |
Small intestine |
Adenocarcinoma |
2 |
Malignant |
|
E6 |
42 |
F |
71 |
Small intestine |
Intermediate grade interstitialoma |
– |
Malignant |
|
E7 |
43 |
M |
70 |
Colon |
Adenocarcinoma |
3 |
Malignant |
|
E8 |
44 |
M |
54 |
Colon |
Intermediate grade interstitialoma |
– |
Malignant |
|
E9 |
45 |
M |
68 |
Rectum |
Adenocarcinoma |
3 |
Malignant |
|
F1 |
46 |
M |
32 |
Rectum |
Intermediate grade interstitialoma |
– |
Malignant |
|
F2 |
47 |
M |
61 |
Liver |
Hepatocellular carcinoma |
2 |
Malignant |
|
F3 |
48 |
F |
17 |
Liver |
Hepatoblastoma |
– |
Malignant |
|
F4 |
49 |
M |
55 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
|
F5 |
50 |
M |
67 |
Prostate |
Adenocarcinoma (prostate tissue sparse) |
– |
Malignant |
|
F6 |
51 |
M |
66 |
Prostate |
Transitional cell carcinoma |
3 |
Malignant |
|
F7 |
52 |
F |
45 |
Uterus |
Leiomyoma |
– |
Malignant |
|
F8 |
53 |
F |
48 |
Uterus |
Endometrial adenocarcinoma |
3 |
Malignant |
|
F9 |
54 |
F |
39 |
Uterus |
Clear cell carcinoma of endometrium |
– |
Malignant |
|
G1 |
55 |
F |
36 |
Uterine cervix |
Squamous cell carcinoma |
3 |
Malignant |
|
G2 |
56 |
F |
39 |
Uterine cervix |
Squamous cell carcinoma |
3 |
Malignant |
|
G3 |
57 |
F |
20 |
Striated muscle |
Embryonal rhabdomyosarcom of left leg |
– |
Malignant |
|
G4 |
58 |
F |
70 |
Rectum |
Malignant melanoma of anus |
– |
Malignant |
|
G5 |
59 |
F |
65 |
Skin |
Basal cell carcinoma of head |
– |
Malignant |
|
G6 |
60 |
M |
46 |
Skin |
Squamous cell carcinoma of left chest wall |
2 |
Malignant |
|
G7 |
61 |
M |
59 |
Mediastinum |
Neurofibroma |
– |
Benign |
|
G8 |
62 |
F |
3 |
Retroperitoneum |
Neuroblastoma of retroperitoneum |
– |
Malignant |
|
G9 |
63 |
M |
60 |
Peritoneum |
Epithelial malignant mesothelioma |
– |
Malignant |
|
H1 |
64 |
M |
42 |
Lymph node |
Diffuse malignant lymphoma |
– |
Malignant |
|
H2 |
65 |
M |
53 |
Lymph node |
Diffuse malignant lymphoma |
– |
Malignant |
|
H3 |
66 |
M |
53 |
Lymph node |
Hodgkin's lymphoma of supraclavicular |
– |
Malignant |
|
H4 |
67 |
F |
68 |
Lymph node |
Diffuse malignant lymphoma of mandible |
– |
Malignant |
|
H5 |
68 |
F |
72 |
Bladder |
Transitional cell carcinoma with squamous metaplasia |
3 |
Malignant |
|
H6 |
69 |
M |
62 |
Bladder |
Low grade leiomyosarcoma |
– |
Malignant |
|
H7 |
70 |
F |
7 |
Bone |
Osteosarcoma of right femur inferior extremity |
– |
Malignant |
|
H8 |
71 |
F |
48 |
Retroperitoneum |
Spindle cell rhabdomyosarcoma of retroperitoneum |
– |
Malignant |
|
H9 |
72 |
F |
60 |
Smooth muscle |
Intermediate grade leiomyosarcoma of left buttock |
– |
Malignant |
|
–
|
– |
M |
58 |
Skin |
Malignant melanoma (tissue marker) |
– |
Malignant |
"-" No grading available. *Tissue dots may be missing or histologically unidentifiable
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
|
|